Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Plunges 10%; BSE HEALTHCARE Index Down 1.0%
Thu, 3 Oct 9:19

MARKSANS PHARMA. Plunges 10%; BSE HEALTHCARE Index Down 1.0%Image source: StarLineArts/www.istockphoto.com

MARKSANS PHARMA. share price has plunged 10% and is presently trading at Rs 270.9.

Meanwhile, the BSE HEALTHCARE index is at 43,814.5 (down 1.0%).

Among the top losers in the BSE HEALTHCARE index today are KIMS (down 9.6%) and Jubilant Pharmova (down 4.1%).

DR. LAL PATHLABS (up 0.7%) and Cadila Healthcare are among the top gainers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 109.6 to Rs 270.9, registering a gain of Rs 161.4 (up 147.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,814.5, registering a gain of 54.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 157.1%), SUVEN PHARMACEUTICALS (up 105.3%) and Glenmark Pharma (up 96.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,002.1 (down 1.5%).

The top losers among the BSE Sensex today are Asian Paints (down 3.0%) and Tata Motors (down 2.9%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,452.9 (down 1.3%). BPCL and Bajaj Auto are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 83,002.1, registering a gain of 17,490.0 points (up 26.7%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 36.8.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Plunges 10%; BSE HEALTHCARE Index Down 1.0%". Click here!